These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 33024120)

  • 21. Effect of berberine on spleen transcriptome and gut microbiota composition in experimental autoimmune uveitis.
    Du Z; Wang Q; Huang X; Yi S; Mei S; Yuan G; Su G; Cao Q; Zhou C; Wang Y; Kijlstra A; Yang P
    Int Immunopharmacol; 2020 Apr; 81():106270. PubMed ID: 32044663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response effect of berberine on bile acid profile and gut microbiota in mice.
    Guo Y; Zhang Y; Huang W; Selwyn FP; Klaassen CD
    BMC Complement Altern Med; 2016 Oct; 16(1):394. PubMed ID: 27756364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
    McMurdie PJ; Stoeva MK; Justice N; Nemchek M; Sieber CMK; Tyagi S; Gines J; Skennerton CT; Souza M; Kolterman O; Eid J
    BMC Microbiol; 2022 Jan; 22(1):19. PubMed ID: 34996347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effects of
    Shin NR; Gu N; Choi HS; Kim H
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome.
    Liu A; Ma T; Xu N; Jin H; Zhao F; Kwok LY; Zhang H; Zhang S; Sun Z
    Microbiol Spectr; 2021 Oct; 9(2):e0085921. PubMed ID: 34612663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial.
    Firouzi S; Majid HA; Ismail A; Kamaruddin NA; Barakatun-Nisak MY
    Eur J Nutr; 2017 Jun; 56(4):1535-1550. PubMed ID: 26988693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
    Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
    J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
    Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
    Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus.
    He Q; Dong H; Guo Y; Gong M; Xia Q; Lu F; Wang D
    Front Endocrinol (Lausanne); 2022; 13():1074348. PubMed ID: 36465656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study.
    Sasaki M; Ogasawara N; Funaki Y; Mizuno M; Iida A; Goto C; Koikeda S; Kasugai K; Joh T
    BMC Gastroenterol; 2013 May; 13():81. PubMed ID: 23657005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
    Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
    Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
    Wang Y; Tong Q; Ma SR; Zhao ZX; Pan LB; Cong L; Han P; Peng R; Yu H; Lin Y; Gao TL; Shou JW; Li XY; Zhang XF; Zhang ZW; Fu J; Wen BY; Yu JB; Cao X; Jiang JD
    Signal Transduct Target Ther; 2021 Feb; 6(1):77. PubMed ID: 33623004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice.
    Li M; Zhou W; Dang Y; Li C; Ji G; Zhang L
    Biomed Pharmacother; 2020 Dec; 132():110953. PubMed ID: 33254441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Berberine on the Gut Microbiota in Apc
    Wang H; Guan L; Li J; Lai M; Wen X
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
    [No Abstract]   [Full Text] [Related]  

  • 37. The mechanism of berberine alleviating metabolic disorder based on gut microbiome.
    Wang H; Zhang H; Gao Z; Zhang Q; Gu C
    Front Cell Infect Microbiol; 2022; 12():854885. PubMed ID: 36093200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Considering gut microbiota in treatment of type 2 diabetes mellitus.
    Adeshirlarijaney A; Gewirtz AT
    Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.
    Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C
    Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine modulates gut microbiota to attenuate cerebral ferroptosis induced by ischemia-reperfusion in mice.
    Wang X; Zhang J; Wang S; Song Z; Sun H; Wu F; Lin X; Jin K; Jin X; Wang W; Lin Q; Wang F
    Eur J Pharmacol; 2023 Aug; 953():175782. PubMed ID: 37245860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.